The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...
CareDx completed the sale of its lab products business to Eurobio Scientific on June 30, 2026, and received $171.2 million in ...
Zacks Investment Research on MSN
CareDx completes Naveris acquisition and expands oncology reach
CareDx CDNA recently completed the acquisition of Naveris, expanding its presence in high-growth specialty oncology. The ...
Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...
EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISION Acceleration of Eurobio’s strategic ...
Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...
ASCO's 2026 annual conference in Chicago featured cutting-edge research on treatment strategies for sarcomas such as GIST and ...
DES MOINES, Iowa (KCRG) - Iowans will get a chunk of a $4.9 million multi-state settlement from a lab overcharging for COVID tests, Attorney General Brenna Bird announced Wednesday. GS Labs was ...
The Federal Communications Commission (FCC) is set to ban a China-based “bad lab” for providing false equipment test results, continuing the government agency’s push toward weeding out network ...
Peer-reviewed journal Clinical Chemistry published the first head-to-head study comparing GraftAssure™ to industry-leading ...
is a deputy editor and Verge co-founder with a passion for human-centric cities, e-bikes, and life as a digital nomad. He’s been a tech journalist for 20 years. Donut Lab’s solid-state battery claims ...
Earlier blood-test detection could help identify pancreatic cancer patients who need more aggressive treatment, an expert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results